There is one sleep-related condition that deserves special attention in the midlife men's health conversation — and it is dramatically underdiagnosed.
Obstructive sleep apnea (OSA) is a condition in which the upper airway repeatedly collapses during sleep, causing partial or complete breathing cessation multiple times per hour. The sleeper partially arouses to restore breathing, often without any conscious awareness of these events. The result is severely fragmented sleep architecture — even when the person believes they slept a full night.
OSA is significantly more prevalent in midlife men than in the general population.5 It is independently associated with testosterone suppression, daytime fatigue, cognitive symptoms, reduced libido, and metabolic dysfunction — the same symptom cluster that frequently drives men to investigate their hormone levels.5
Here is the clinical significance of that overlap: the symptoms of untreated OSA and the symptoms of low testosterone are, in many cases, clinically indistinguishable. A man with undiagnosed OSA who gets his testosterone tested may receive a low result — not because his endocrine system has failed, but because the sleep disruption from OSA is chronically suppressing his hormonal production.
The Endocrine Society's clinical guidelines for testosterone therapy explicitly list untreated severe obstructive sleep apnea as a contraindication to initiating testosterone replacement.6 A guideline-adherent physician should not start TRT until sleep apnea has been evaluated and managed.
If you are experiencing unexplained fatigue, non-restorative sleep, morning headaches, or have been told you snore heavily or stop breathing during sleep, OSA screening is not an optional add-on to the hormone conversation. It is a necessary first step.